Our objectives were to investigate the effects of CB on IFN-I production, particularly in the context of SLE, where overactivation of the TLR7 pathway in pDCs drives excessive production of type I interferons, contributing to disease pathology. This evidence concerns the gene TLR7 and systemic lupus erythematosus.